Total synthesis of bryostatin 1.
Keck GE, Poudel YB, Cummins TJ, Rudra A, Covel JA.
J Am Chem Soc · research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/ja110198y PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för bryostatin 1. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
39 hitsChallenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ.
Irie K, Yanagita RC, Nakagawa Y.
Med Res Rev · research support, non-u.s. gov't; review; journal article · DOI 10.1002/med.20220New approaches to the total synthesis of the bryostatin antitumor macrolides.
Hale KJ, Manaviazar S.
Chem Asian J · review; journal article · DOI 10.1002/asia.200900634Bryostatin-1: pharmacology and therapeutic potential as a CNS drug.
Sun MK, Alkon DL.
CNS Drug Rev · research-article; review; journal article · DOI 10.1111/j.1527-3458.2006.00001.xBryostatin-1: a novel PKC inhibitor in clinical development.
Kortmansky J, Schwartz GK.
Cancer Invest · research support, u.s. gov't, p.h.s.; review; journal article · DOI 10.1081/cnv-120025095The rational design of potential chemotherapeutic agents: synthesis of bryostatin analogues.
Wender PA, Hinkle KW, Koehler MF, Lippa B.
Med Res Rev · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; review; journal article · DOI 10.1002/(sici)1098-1128(199909)19:5<388::aid-med6>3.0.co;2-hModulation of ara-C induced apoptosis in leukemia by the PKC activator bryostatin 1.
Grant S.
Front Biosci · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; review; journal article; research support, n.i.h., extramural · DOI 10.2741/a187Bryostatin 1: differentiating agent from the depths.
Stone RM.
Leuk Res · comment; review; journal article · DOI 10.1016/s0145-2126(96)00123-3Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1.
Steube KG, Drexler HG.
Leuk Lymphoma · comparative study; review; journal article · DOI 10.3109/10428199309148517